Reverse transcriptase polymerase chain reaction was used to determine the amount of overexpression of the ampC gene in 52 cefoxitin-resistant Escherichia coli clinical isolates that had previously characterized mutations in their ampC promoter/ attenuator regions. The results showed that mutations that create a consensus À 35 box (TTGACA) are the most important factor in strengthening the ampC promoter, followed by base pair insertions that increase the distance between the À 35 and À 10 boxes to 17 or 18 bp. Mutations in the À 10 box are of lesser importance and those in the attenuator region appear to have little effect on ampC expression. Three strains overexpress ampC due to the effect of insertion elements located in the ampC promoter regions. Further, the data show that there is no correlation between ampC overexpression and the minimum inhibition concentration of cefoxitin in clinical isolates. Overall, the data indicate that a combination of ampC promoter mutations and other strain-specific factors combine to contribute to the magnitude of cefoxitin resistance in E. coli.
Introduction
In Escherichia coli, chromosomal cephalosporinase gene (ampC) is transcribed constitutively from a weak promoter and is subject to attenuation (Jaurin et al., 1981 (Jaurin et al., , 1982 . Overexpression of the chromosomal ampC gene can result in resistance to ampicillin, cefoxitin and expanded-spectrum cephalosporins. The primary mechanism of AmpC hyperproduction is mutation of the ampC promoter region to one that more closely resembles the E. coli consensus sigma 70 promoter sequence, a TTGACA À 35 box separated by 17 bp from a TATAAT À 10 box (Hawley & McClure, 1983) . Besides mutations that change the wild-type À 35 and À 10 boxes to ones more closely resembling the E. coli consensus boxes, insertions that increase the space between them from 16 to 17 or 18 bp can occur (Jaurin et al., 1982; Olsson et al., 1983; Caroff et al., 1999 Caroff et al., , 2000 Forward et al., 2001; Corvec et al., 2002; Siu et al., 2003) . In addition, mutations can occur that create an alternate displaced promoter with new À 35 and À 10 boxes separated by 17 bp (Olsson et al., 1982; Caroff et al., 1999 Caroff et al., , 2000 Nelson & Elisha, 1999; Forward et al., 2001) . Mutations also occur in the attenuator region and are thought to result in higher ampC expression levels through destabilization of the mRNA hairpin structure (Jaurin et al., 1981) .
In a previous report, 52 different ampC promoter/ attenuator variant types were identified from a collection of cefoxitin-resistant E. coli isolated from Canadian hospitals (Mulvey et al., 2005) . Here, that study is extended using reverse transcriptase polymerase chain reaction (RT-PCR) to determine the effect of the promoter/attenuator variations on ampC expression and whether overexpression levels can be correlated to the magnitude of cefoxitin resistance in these clinical strains.
Materials and methods

Bacterial strains and antimicrobial susceptibility
The ampC promoter/attenuator variants examined in this study were from a subset of cefoxitin resistant E. coli [minimum inhibition concentration (MIC) of cefoxitin Z32 mg L À1 ] that were potential ESBL producers, as described previously (Mulvey et al., 2005) . A promoter type has been defined previously as follows: a unique sequence found for a 191 bp region that encompasses the promoter region ( À 35, À 10, and spacer region), the attenuator region (117 to 137) and the first 41 bp of the coding sequence of the ampC gene (Mulvey et al., 2005) . One isolate harbouring each promoter type was chosen for ampC expression analysis. In total, 49 ampC promoter/attenuator variant isolates plus three isolates with two different types of insertion sequences in the ampC promoter region were studied. Escherichia coli ATCC 25922 was used as the control for a normally expressed (low level constitutive) ampC gene. The MICs for cefoxitin were determined using the Etest (AB Biodisk, Solna, Sweden). The strains used have been characterized previously for the possession of secondary b-lactamases (Mulvey et al., 2005) .
RNA isolation and RT-PCR
Clinical isolates were grown in Luria-Bertani broth to the mid-log phase and RNA was isolated with a Qiagen RNEasy RNAprotect Mini Kit (Qiagen Inc., Mississauga, ON). A SuperScript III Platinum Two-step Quantitative RT-PCR kit (Invitrogen Corp., Burlington, ON) was used to assay for expression of ampC and glyceraldehyde dehydrogenase (gapA) using the AmpC LUX353FL/353FL_361RU and GapA LUX620FL/620FL_671RU primer sets with each reaction performed in triplicate, as described previously (Tracz et al., 2005) . Real-time PCR was performed in 96-well plates in an ABI Prism 7900 HT (Applied Biosystems, Foster City, CA), and data were analysed using SEQUENCE DETECTION software 2.0 (Applied Biosystems). The delta-delta cycle threshold method (2 ÀDDC T ) was used for the relative quantification of ampC expression between isolates (Livak & Schmittgen, 2001 ). Controls included a no-template negative control, an E. coli ATCC 25922 genomic DNA positive control and a PCR control to confirm absence of DNA in RNA samples.
Results and discussion
In a previous study, ampC promoter regions were analysed from 183 cefoxitin-resistant E. coli isolated from Canadian hospitals and 49 sequence variants were identified when compared with the wild-type E. coli K12 sequence (Mulvey et al., 2005) . In order to relate the ampC promoter structure with gene expression, a real-time RT-PCR assay was used for the relative quantification of ampC gene expression as compared with that in E. coli ATCC 25922, a strain with a wild-type promoter providing low-level constitutive expression (Tracz et al., 2005) . To facilitate data analysis, promoter sequence types were divided into 12 groups based upon a known functional element(s) containing mutations (Fig. 1 , Table 1 ). The functional elements are the À 35 and À 10 boxes and the spacer region of the wild-type promoter, the À 35 and À 10 boxes of the alternate displaced promoter, and the attenuator region. Promoter types may also have Fig. 1 . Sequence of the Escherichia coli ATCC 25922 ampC promoter region. The sequence elements referred to in the text are indicated. Numbering is according to Jaurin et al. (1981) .
mutations at other positions outside of the functional element, and one group labelled 'Other' had only mutations outside of functional elements. Three strains that had insertion elements located in their ampC promoter regions were also analysed.
Mutations in wild type promoter
Promoter types in this group (n = 6) contained mutations in the wild-type À 35 box (positions À 30 to À 35) and/or À 10 box (positions À 8 to À 13). All contained the T ! A transversion at position À 32 that created a À 35 box identical to the E. coli consensus TTGACA (pertinent nucleotide in bold) (Hawley & McClure, 1983) . The results showed that these promoters were overexpressed 8-46-fold. One promoter type, type 26, also had a C ! T transition at position À 11 that created a À 10 box identical to the E. coli consensus TATAAT. However, promoter type 26 (43-fold) was expressed similar to type 24 (45-fold), suggesting that the À 32 mutation is most responsible for the increase in promoter strength, and that the mutation in the À 10 box had a negligible effect on promoter strength. Two promoter types, types 9 and 26, also included a G ! A transition at position À 28 of the spacer region. Considering that three promoter types in the 'Other' category showed this change and overexpression was only 1-3-fold, there appears to be no or negligible contribution of the À 28 change to promoter strength.
Mutations in wild-type promoter and attenuator
Except for a single type, type 35, promoters in this group contained the T ! A transversion at À 32 and also had mutations in the attenuator region (117 to 137). Type 35 had the C ! T transition at À 11 as well as mutations in the attenuator. The results show that the ampC gene was overexpressed 21-68-fold, except for promoter type 35, which was overexpressed only about threefold. These results support the above supposition that a consensus À 35 box is more important than a consensus À 10 box in determining ampC promoter strength. In addition, as the results for the majority of types here are similar to the group with mutations in the wild-type promoter, 21-68-fold vs. 8-46-fold, respectively, it would appear that mutations in the attenuator have a negligible role in increasing promoter strength. One promoter type, type 28, contained a C ! T transition at position À 29 in the spacer region, but as for the change at position À 28, it is unlikely that this change had a major impact on promoter strength.
Mutations in the attenuator
Promoter types in this group (n = 3) had mutations in the attenuator, positions 117 to 137. The ampC gene was expressed at levels similar to the control constitutive level in these promoter types (1-2-fold). Thus, as stated above, it appears that attenuator mutations thought to destabilize the stem loop have only a small role in increasing ampC promoter strength.
Mutations that create an alternate displaced promoter
Promoter types in this group (n = 5) had mutations that led to an alternate displaced promoter consisting of a À 35 box at positions À 37 to À 42 separated by 17 bp from a À 10 box at À 14 to À 19 (Fig. 1) . A C ! T transition at position À 42 to create the alternate À 35 box, TTGACA, and/or a G ! A transition at position À 18 created the alternate À 10 box, TATCGT. A single type, type 15, besides the change at À 18, had a G ! A transition at À 15 to create a TATCAT À 10 box. These results further support the importance of a consensus À 35 box to ampC overexpression. The two types with the À 42 C ! T change were overexpressed about 20-fold, whereas the three types without it but with the À 18 change were overexpressed only 1.5-3.7-fold.
Mutations in the attenuator and those that create an alternate displaced promoter
The combination of mutations that form an alternate displaced promoter and mutation in the attenuator produced the highest levels of ampC expression observed in this study. Two promoter types with the À 42 and À 18 transitions and a mutated attenuator (types 33 and 34) were found to have 140-and 280-fold ampC expression levels, respectively. Two other promoter types with the same transitions at À 42 and À 18, types 29 and 31, were overexpressed 38-and 60-fold, respectively. In contrast, sequence type 22, which had a À 18 transition and a mutated attenuator, showed virtually no increase in ampC expression over the wild type. As mentioned above, the data show that attenuator mutations play a small role in promoter overexpression.
Mutations that create a consensus À 35 box and that create an alternate À 10 box A single promoter type, type 48, had the À 32 T ! A transversion that created a consensus À 35 box in the wildtype promoter, and the À 18 G ! A transition in the alternate À 10 box. The ampC gene was overexpressed about 124-fold most likely due to the consensus À 35 box.
Spacer insertions with or without attenuator mutations
We identified three promoter types with a single bp insertion between positions À 13 and À 14 (position À 13.1 in Table 1 ), either a G or a T, that increased the spacer between the wild-type À 35 and À 10 boxes from 16 to 17 bp. The results indicated a 24-61-fold increase in ampC promoter expression in these strains. The combination of a single nucleotide insertion and an attenuator mutation in four promoter types increased ampC expression 41-64-fold, showing that the main contributor to promoter strength is the increased spacer length. A single promoter type, type 25, had a two-nucleotide insertion between À 13 and À 14 (a TA) and this promoter was overexpressed 19-fold. Five promoter types combined the two-nucleotide insertion (either a GT or TA) with mutations in the attenuator region and these were overexpressed 27-83-fold. Thus, an increase in the spacer region of two nucleotides to 18 bp produces a promoter at least as efficient as one with a 17 bp spacer. Attenuator mutations have only a negligible or a small additive effect in combination with the spacer insertions.
Other mutations
Six promoter types were found to have changes only outside of the promoter elements. These included changes at À 1, 16, 158, 163, 170 and 181, with the latter three occurring in the ampC coding region. Expression was generally measured at about wild-type levels (0.5-2.6-fold). These changes often occurred with other promoter element changes in other types, but it is likely that their contribution to ampC overexpression is negligible. As has been speculated previously, the changes at 163, 170 and 181 lead to amino acid changes in the leader peptide region and may have an effect on transfer of the enzyme precursor into the periplasmic space, although this awaits further evidence (Mulvey et al., 2005) . Except for the two strains that also harboured a bla CMY-2 b-lactamase gene, the mechanism of cefoxitin resistance in these strains is unknown.
Insertion sequences
Two sequence types that had insertion elements in their ampC promoter region were previously identified (Mulvey et al., 2005) . One strain was found to have IS911 inserted between 124 and 125, which provided a À 35 box (TTGACC) separated from the wild-type À 10 box by 17 bp. The ampC gene in this strain was overexpressed 205-fold. Two strains had an IS10 element inserted between 135 and 136 near the 3 0 -end of the attenuator region. It is postulated that ampC expression is driven by the strong pOUT promoter of IS10 resulting in 9-10-fold overexpression in these two strains (Simons et al., 1983) . A laboratory mutant of E. coli has been described that contained a hybrid ampC promoter formed by the insertion of IS2 between positions À 14 and À 15 that was overexpressed 20-fold (Jaurin & Normark, 1983) .
Relationship between MICs of cefoxitin and promoter type
The promoter types in this study were selected from E. coli strains from Canadian hospitals that were resistant to cefoxitin (Z32 mg L À1 ) as determined by broth microdilution (Mulvey et al., 2005) . In that study, the highest concentration of cefoxitin tested was 64 mg L À1 and hence the highest value that could be assigned to a strain was Z64 mg L À1 . In order to determine whether promoter type (fold overexpression) was directly related to MIC of cefoxitin, Etest strips were used to allow examination of a wider range of MICs (Table 1) . Despite being examined by Etest, the six strains that harboured bla CMY-2 were not considered in the analysis here as the b-lactamase would be expected to contribute to the overall cefoxitin resistance. . The lack of a correlation between type of ampC promoter mutation and b-lactam resistance has been described previously, as has a lack of correlation between abundance of ampC transcript and b-lactam resistance (Caroff et al., 1999; Nelson & Elisha, 1999) . In this study, the complete ampC gene was not studied and so one cannot rule out variant AmpC proteins with amino acid changes leading to different resistance levels. It has been shown that strains with variant AmpC proteins exhibit altered b-lactam resistance profiles (Morosini et al., 1998; Mammeri et al., 2004) . Further, altered porin expression patterns have been shown to contribute to b-lactam resistance (Martínez-Martínez et al., 2000; Ananthan & Subha, 2005) Hence, it is apparent that in the absence of an acquired class C blactamase, cefoxitin-resistant E. coli often have ampC promoter mutations, but other strain-specific factors play a role in determining the MIC of cefoxitin.
Conclusions
The present results showed that 83% of strains with promoter types with mutations in functional elements or that contained an insertion sequence in their ampC promoters overexpressed ampC 8-280-fold (Table 1) . Strains with promoter types with mutations only in the attenuator region or that did not contain mutations creating a consensus À 35 box only expressed ampC 1-4-fold, similar to strains with promoter types with mutations outside of functional elements (Table 1 ). This study supports previous studies that showed that it is the creation of a consensus À 35 box, whether by a T ! A transversion at position À 32 or a C ! T transition at position À 42, that is the most dominant factor in strengthening the ampC promoter (Jaurin et al., 1982; Olsson et al., 1982 Olsson et al., , 1983 Caroff et al., 1999 Caroff et al., , 2000 Nelson & Elisha, 1999; Forward et al., 2001; Corvec et al., 2003) . The results also support previous studies showing that optimal spacing between À 35 and À 10 boxes is also an important factor contributing to promoter strength (Jaurin et al., 1981; Siu et al., 2003) . Mutations in the À 10 box or attenuator region by themselves have a negligible effect, although when combined with other more important mutations, they may contribute to overall ampC overexpression. Although mutations that create a consensus À 35 box and ones that increase the spacer region can lead to clinical cefoxitin resistance (at least 32 mg L À1 ), it appears that an interplay of ampC overexpression and other strain-specific factors can affect the degree of resistance (i.e. MIC of cefoxitin) of individual strains. 
